Zenas BioPharma (ZBIO) Revenue (2023 - 2025)

Zenas BioPharma (ZBIO) recorded quarterly Revenue of $10.0 million in Q1 2025, up 100.0% quarter-over-quarter from $5.0 million in Q4 2024.

Zenas BioPharma (ZBIO) Revenue (2023 - 2025) Analysis & Trends

Zenas BioPharma's Revenue history runs 3 years deep, the most recent figure standing at $10.0 million for Q1 2025.

  • In Q1 2025, Revenue changed N/A year-over-year to $10.0 million; the TTM figure through Dec 2025 stood at $10.0 million (up 100.0% YoY), while the FY2025 annual figure was $10.0 million, up 100.0% from the prior year.
  • Revenue was $10.0 million for Q1 2025 at Zenas BioPharma, up from $5.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $50.0 million in Q3 2023 to a low of $5.0 million in Q4 2024.
  • Historically, Revenue has averaged $21.7 million across 3 years, with a median of $10.0 million in 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Zenas BioPharma 1.10 Bn 379.43 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 10.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2023 50.00 Mn